The major objective of this course is to provide a detailed insight into the practical aspects and approaches of process scale-up for different unit operations and technologies.
A New Chairman at the ISO IDMP Implementation online conference
Timm Pauli has officialy become our new chairman for the ISO IDMP Implementation online conference. He will be keeping an eye towards its smooth execution and will add a great sense of professionalism to the event as his background speaks for himself.
A chairman, as the highest authority at an event, brings his opening speech and introduces each speaker. During the whole event he opens the Q&A sessions after speakers' presentations and gives a little feedback or poses questions at the end. Perhaps the biggest input is the chairman's final remarks, which have the power to sum things up, underline what was important and emphasize what things the attendees will walk away with.
Timm is Head of Regulatory Operations at Pharmalex Germany, where is responsible for all electronic submission activities, regulatory information management and related topics. He has already spoken at three of our online conferences:
- eCTD Submission Updates, Oct. 15, 2014
- eSubmission Updates 2015, Jun 17, 2015
- Generics: EU Regulatory Landscape, Oct 20, 2015
So we asked Timm, what his experiences have been with our events:
What would you highlight as interesting features included in these online conferences?
Fleming. online conferences offer simple yet high-quality access to hot topics within the domain of Regulatory Affairs and allow easy exchange with key experts. The conferences are well-prepared and professionally executed.
According to your experience, what kind of practical information can attendees usually take from them?
Those conferences I participated in the past focused on current developments as well as new and changed requirements in the context of Regulatory Affairs or Regulatory Operations. In most cases there is a good mixture of sharing theoretical background and practical experiences.
Do you consider your interaction with our delegates and speakers as a useful for you as well?
Even during the preparation, normally there are already good discussions with other speakers and contributors. And also during the event itself I am always excited about the good questions and feedback from participants, which make the events interesting and interactive sessions.
Interested in this topic?
Targeted Drug Delivery
Gain detailed overview of the newest strategies in drug delivery and targeting.
Next Generation Antibody Therapeutics
This focused 2-day training will cover the discovery, engineering and production of next-generation antibodies, antibody fragments, bispecific Abs, innovative ADCs and more. Follow the path from their discovery and selection through engineering and expression to production and regulatory issues.
White Paper: Beyond the Cold Chain
Take a Good Look at the Future of Corporate Universities
There are four things corporate universities can do to avoid becoming irrelevant in the digital age.
Ready for the new GCP ICH E6 (R2) addendum?
On the 23rd of July 2015, the EMA's Committee for Human Medicinal Products released the Guideline for Good Clinical Practice E6(R2) for consultation. On the 14th of June 2017, it will come into effect and influence everyone involved in the clinical research process. What does it mean to pharma and biotech companies, sponsors, CROs, research institutes and third-party organizations?